Adamas Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug Post author:Sam Post published:August 24, 2017 Post category:BioPharma August 25, 2017By Mark Terry, BioSpace.com… Source: BioSpace You Might Also Like German Biotech InflaRx Snags $100M in IPO November 8, 2017 Mysterious NuBiyota Inks Lease for Former Pfizer Campus December 7, 2017 Adocia Announces First Quarter 2017 Financial Results April 17, 2017